Breaking News Instant updates and real-time market news.

SHPG

Shire

$187.70

-3.35 (-1.75%)

07:08
10/17/16
10/17
07:08
10/17/16
07:08

Shire announces update to Vyvanse labeling

Shire announces an update to the Vyvanse labeling to include information regarding the approval of a supplemental New Drug Application, or sNDA, FDA. The labeling will now include maintenance of efficacy data from SPD489-346, the first-ever longer-term pharmacologic study in adults with moderate to severe binge eating disorder. Results from SPD489-346, which were announced in July 2015, indicated that Vyvanse demonstrated significant maintenance of efficacy compared to placebo based upon the primary endpoint of time to relapse. Vyvanse is approved in the U.S. for adults with moderate to severe B.E.D. Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective for the treatment of obesity.

  • 26

    Oct

SHPG Shire
$187.70

-3.35 (-1.75%)

08/03/16
LEER
08/03/16
NO CHANGE
Target $231
LEER
Outperform
Shire price target raised to $231 from $213 at Leerink
Leerink analyst Jason Gerberry raised his price target for Shire to $231 from $213 on valuation after the company reported "solid" Q2 results. The analyst reiterates an Outperform rating on the shares.
08/31/16
JEFF
08/31/16
NO CHANGE
Target $262
JEFF
Buy
Shire making right moves in dry eye market, says Jefferies
After hosting meetings with management, Jefferies analyst David Steinberg believes Shire (SHPG) is making "all the right moves" to make its dry eye drug Xiidra a potential $2B peak product in the U.S. Shire's Xiidra is competing with Allergan's (AGN) $1.4B dry eye drug Restasis, Steinberg tells investors in a research note. The analyst does not think Shire will have any problem exceeding the drug's consensus sales forecast of $200M for next year. He keeps a Buy rating on the shares with a $262 price target.
09/26/16
HSBC
09/26/16
DOWNGRADE
HSBC
Hold
Shire downgraded to Hold from Buy at HSBC
HSBC analyst Steve McGarry downgraded SHire to Hold saying valuation is no longer compelling.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

, VOD

Vodafone

09:00
02/23/17
02/23
09:00
02/23/17
09:00
Periodicals
SoftBank denies looking for stake in Vodafone Indian unit, Bloomberg reports »

SoftBank (SFTBF) has…

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

VOD

Vodafone

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
02/23/17
02/23
09:00
02/23/17
09:00
General news
FX Action: The dollar »

FX Action: The dollar…

SSD

Simpson Manufacturing

$44.24

-0.62 (-1.38%)

08:59
02/23/17
02/23
08:59
02/23/17
08:59
Hot Stocks
Simpson Manufacturing to adopt proxy access bylaws amendment »

Simpson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

08:57
02/23/17
02/23
08:57
02/23/17
08:57
Hot Stocks
Kohl's says has 'nothing specific in mind' on M&A »

Says company in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

AGN

Allergan

$246.32

-0.84 (-0.34%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Periodicals
Allergan CEO proposes Trump lead drug price negotiations, Bloomberg reports »

Allergan CEO Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 04

    May

BAC

Bank of America

$24.79

0.01 (0.04%)

, TSLA

Tesla

$273.51

-3.88 (-1.40%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Options
Notable open interest changes for February 23rd »

Wednesday's total…

BAC

Bank of America

$24.79

0.01 (0.04%)

TSLA

Tesla

$273.51

-3.88 (-1.40%)

JCP

J.C. Penney

$7.05

-0.01 (-0.14%)

FB

Facebook

$136.12

2.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 24

    Feb

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Hot Stocks
Breaking Hot Stocks news story on Tennant 

Tennant trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

, VOD

Vodafone

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Periodicals
SoftBank in talks to buy stake in Vodafone Indian unit, The Economic Times says »

Softbank (SFTBF) could…

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

VOD

Vodafone

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:55
02/23/17
02/23
08:55
02/23/17
08:55
General news
The 6k U.S. initial claims rise to 244k »

The 6k U.S. initial…

THG

Hanover Insurance

$91.08

0.43 (0.47%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Hanover Insurance to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

HNR

Harvest Natural

$6.68

0.04 (0.60%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Harvest Natural to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:54
02/23/17
02/23
08:54
02/23/17
08:54
Hot Stocks
Tennant to reduce 3% of global workforce »

Tennant announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Earnings
Tennant sees 2017 adjusted EPS $2.50-$2.70, consensus $2.83 »

On an as adjusted and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

STNG

Scorpio Tankers

$4.28

-0.01 (-0.23%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Upgrade
Scorpio Tankers rating change  »

Scorpio Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

KSS

Kohl's

08:52
02/23/17
02/23
08:52
02/23/17
08:52
Hot Stocks
Kohl's sees significant improvement in Q1 gross margin »

Sees significant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:51
02/23/17
02/23
08:51
02/23/17
08:51
Earnings
Tennant reports Q4 EPS 85c, consensus 76c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LMRK

Landmark Infrastructure

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Syndicate
Breaking Syndicate news story on Landmark Infrastructure »

Landmark Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

KSS

Kohl's

, UA

Under Armour

$19.78

0.09 (0.46%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Hot Stocks
Kohl's CEO believes uncertainty in sector will continue »

Kohl's (KSS) says…

KSS

Kohl's

UA

Under Armour

$19.78

0.09 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

, AGN

Allergan

$246.32

-0.84 (-0.34%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Conference/Events
Piper Jaffray healthcare/pharma analyst holds analyst/industry conference call »

Analyst Schimmer, along…

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

AGN

Allergan

$246.32

-0.84 (-0.34%)

BMY

Bristol-Myers

$55.35

0.57 (1.04%)

ENTA

Enanta

$28.18

-0.36 (-1.26%)

GALT

Galectin Therapeutics

$1.71

-0.23 (-11.86%)

GILD

Gilead

$68.83

-0.46 (-0.66%)

GLMD

Galmed

$4.09

-0.16 (-3.76%)

ICPT

Intercept

$122.79

-2.66 (-2.12%)

MRK

Merck

$65.29

-0.19 (-0.29%)

RGLS

Regulus

$1.08

-0.025 (-2.27%)

VKTX

Viking Therapeutics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 02

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

08:50
02/23/17
02/23
08:50
02/23/17
08:50
General news
Atlanta Fed centrist Lockhart sees the pendulum swinging »

Atlanta Fed centrist…

W

Wayfair

$41.26

1 (2.48%)

08:49
02/23/17
02/23
08:49
02/23/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Wayfair »

Wayfair down 10.3% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TWX

Time Warner

$96.32

-0.1 (-0.10%)

, T

AT&T

$41.59

-0.14 (-0.34%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Periodicals
Time Warner IR head to lead AT&T integration, THR reports »

Time Warner (TWX) head of…

TWX

Time Warner

$96.32

-0.1 (-0.10%)

T

AT&T

$41.59

-0.14 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

, ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

FIT

Fitbit

$5.88

-0.16 (-2.65%)

NAK

Northern Dynasty

$1.39

-0.27 (-16.27%)

BX

Blackstone

$30.32

-0.23 (-0.75%)

PCLN

Priceline

$1,651.74

4.74 (0.29%)

TBT

ProShares UltraShort 20+ yr Trsry

$39.71

-0.14 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 28

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:45
02/23/17
02/23
08:45
02/23/17
08:45
Hot Stocks
Tennant announces agreement with Ambienta to acquire IPC Group for $350M »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

08:45
02/23/17
02/23
08:45
02/23/17
08:45
General news
Treasury Action: yields remained downwardly biased »

Treasury Action: yields…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.